Publication | Closed Access
Maintenance infliximab (Remicade) is safe, effective and steroid-sparing in Crohn's disease: Preliminary results from the accent i trial
27
Citations
0
References
2001
Year
InflammationChronic Inflammatory DiseasesAnti-inflammatoryMaintenance InfliximabImmunologyGastroenterologyPreliminary ResultsAccent I TrialUlcerative ColitisMedicineRheumatoid Arthritis
No additional data available for this publication yet. Check back later!